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Background: Annually, influenza A viruses circulate the world causing wide-spread sickness, economic loss, and
death. One way to better defend against influenza virus-induced disease may be to develop novel host-based
therapies, targeted at mitigating viral pathogenesis through the management of virus-dysregulated host functions.
However, mechanisms that govern aberrant host responses to influenza virus infection remain incompletely
understood. We previously showed that the pandemic H1N1 virus influenza A/California/04/2009 (H1N1; CA04) has
enhanced pathogenicity in the lungs of cynomolgus macaques relative to a seasonal influenza virus isolate
(A/Kawasaki/UTK-4/2009 (H1N1; KUTK4)).
Results: Here, we used microarrays to identify host gene sequences that were highly differentially expressed (DE) in
CA04-infected macaque lungs, and we employed a novel strategy – combining functional and pathway enrichment
analyses, transcription factor binding site enrichment analysis and protein-protein interaction data – to create a
CA04 differentially regulated host response network. This network describes enhanced viral RNA sensing, immune
cell signaling and cell cycle arrest in CA04-infected lungs, and highlights a novel, putative role for the
MYC-associated zinc finger (MAZ) transcription factor in regulating these processes.
Conclusions: Our findings suggest that the enhanced pathology is the result of a prolonged immune response,
despite successful virus clearance. Most interesting, we identify a mechanism which normally suppresses immune
cell signaling and inflammation is ineffective in the pH1N1 virus infection; a dyregulatory event also associated with
arthritis. This dysregulation offers several opportunities for developing strain-independent, immunomodulatory
therapies to protect against future pandemics.
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In April of 2009, a new pandemic H1N1 (pH1N1) influen-
za virus strain emerged in Mexico [1], and the subsequent
global pandemic claimed more than 18,000 lives [2].
Human infections with pH1N1 tended to be mild with
typical clinical symptoms (e.g., fever, sore throat, vomiting,
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distribution, and reproduction in any mediumdeath occurred, autopsies showed necrotizing bronchitis,
a symptom that has also been observed in previous pan-
demics [3,4]. Loss of life during the 2009 pandemic was
minor compared to other pandemics (e.g., the 1918
Spanish influenza pandemic, which caused an estimated
50 million deaths worldwide [5]); however, 2009 pH1N1
infections have resulted in more severe illness in young,
previously healthy individuals, which is atypical for seaso-
nal influenza virus isolates [6-8].
Currently licensed antiviral compounds against influen-
za virus (e.g., oseltamavir) interfere with specific functions
of viral proteins and are one defense against seasonal and
newly emerging pandemic influenza viruses. However,tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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H1N1 virus strains in 2007–2008 [9] and the existence of
resistant pH1N1 virus isolates [10] strongly underscore
the urgent need for the development of novel strategies to
alleviate influenza virus-induced disease. As an alternative
to directly inhibiting viral proteins, aspects of the host
response that strongly correlate with host pathology could
be targeted to reduce the overall severity of infection. Such
therapies may be more robust against the emergence of
drug-resistant strains because they do not target influenza
virus-specific gene products, which are subject to drug-
mediated selective pressure. Therefore, a better under-
standing of the mechanisms contributing to influenza
virus pathogenesis is needed to provide the basis for the
development of novel host-modulatory therapies. We have
reported that a pH1N1 isolate (influenza A/California/04/
2009 [H1N1], referred to as CA04) is more pathogenic
than a seasonal H1N1 isolate in several mammalian mo-
dels, including cynomolgus macaques [11]. Specifically,
CA04-infected macaques exhibited higher body tempera-
tures, more efficient virus replication in both the upper
respiratory tract and lungs, increased production of pro-
inflammatory cytokines (e.g., CCL2 and IL6), and more
severe lung lesions at both early (3 days) and late (7 days)
times post-infection. In addition, we observed an in-
creased presence of inflammatory infiltrates in alveolar
spaces and more abundant viral antigen staining of both
type I and type II pneumocytes. These pathological char-
acteristics are similar to those that distinguish highly
pathogenic avian H5N1 and 1918 influenza viruses from
lower pathogenicity isolates [12-14], suggesting a common
host response theme that may contribute to increased
pathogenicity phenotypes for diverse influenza viruses.
However, the specific mechanisms underlying the severity
of CA04 virus pathogenicity remain to be fully elucidated.
In this study, we undertook a unique bioinformatics
approach to identify host processes that might be respon-
sible for the enhanced pathology of CA04 in macaques.
Other studies have used microarray analysis in conjunc-
tion with bioinformatics tools (e.g., Ingenuity Pathway
Analysis (IPA) or DAVID [15]) to dissect the response to
influenza virus infection, primarily at the level of the out-
come of host signaling (i.e., differentially expressed trans-
cripts) [13,14,16-18]. However, these studies typically
have used such tools in isolation, and largely have not
attempted to predict causative regulatory influences me-
diated by factors existing outside of the primary dataset.
Here, we have combined process-level and cell-specific
functional enrichment analyses of highly differentially
expressed transcripts in CA04-infected lung tissues, identi-
fication of putative transcription factors involved in regulat-
ing differential expression, canonical pathway enrichment,
and protein-protein interactions to develop an integrated
pathogenicity-associated host response network. Thisnovel approach revealed not only differentially regu-
lated pathways and differences in immune cell populations
that correlate with enhanced CA04 pathogenicity, but
importantly, also identified critical regulatory intermedi-
aries between these correlates. We suggest that the result-
ing network can be systematically explored for novel
therapeutic intervention.
Results
CA04 may promote inflammation through increased
expression of chemotactic molecules and caspase-1
induction and suppression of glutathione S-transferase
(GST) expression
The CA04 virus induces more severe lesions in the lungs
of cynomolgus macaques relative to a seasonal influenza
virus isolate (A/Kawasaki/UTK-4/09 [H1N1; referred to
KUTK4]) [11]. To identify host functions and pathway
activity that might explain this difference, we compared the
global transcriptional response of CA04- and KUTK4-
infected lung tissues derived from the animals reported in
[11]. Microarray analysis of RNA isolated from within gross
lesions identified 101 differentially expressed (DE; See
Methods) transcripts between the two infections on day 3
p.i. and 854 DE transcripts on day 7 p.i. More than half of
the DE transcripts from day 3 were also DE on day 7, and
the overlap between time points was significant (Fisher’s
Exact test, P < 10−16). A table summarizing the DE test
results is shown in Additional file 1, and total lists of DE
transcripts fromdays 3 and 7 are available inAdditional file 2.
It is important to note that, while lung lesion severity varied
between samples (Additional file 3), principle component
analysis did not identify any relationships between the sam-
ples based on lesion severity (data not shown).
We first focused on genes commonly associated with
inflammation and apoptosis (Figure 1). Enhanced up-
regulation of interferon (IFN)-stimulated genes (ISGs)
was observed on day 3 and day 7 p.i., indicating that
CA04 induced more robust type I IFN signaling than did
KUTK4 (Additional file 1). On day 3 p.i., three che-
mokines (CCL13, CCL2 and CCL3L3) were more up-
regulated with CA04 infection; and these together with
four others (CCL11, CCL4, CCL8 and CXCL3) were also
more up-regulated on day 7. In general, the up-regulated
chemokines perform pleiotropic recruitment activities
against multiple immune cell subtypes; however, CCL2
and CCL3L3 exhibit potent chemotactic activity toward
monocytes [19,20]. On day 7, we also observed enhanced
expression of chemokine receptors that are abundant on
monocytes (CCR1 and CCR2), interleukins that are pri-
marily expressed and secreted by macrophages (IL10
and IL1A) and molecules that regulate lymphocyte acti-
vities (IL21R, IL4R, and IL7). Collectively, these observa-
tions are consistent with detailed histopathology analysis













































Figure 1 CA04 differentially expressed genes. The transcription profiles of select DE genes on day 3 (top) and day 7 p.i (bottom). Each
column represents the gene expression profile of an individual macaque lung tissue sample; gene expression levels for two samples acquired
from a uninfected animal are also shown (to the left) for reference. The lesion severity, as described in (11), for each sample is shown at the
bottom (Damage) of each heat map. White indicates no lesions; blue represents lung lesions with severe alveolar wall thickening; yellow indicates
mild lung lesions with some antigen-positive cells present; orange indicates severe lesions containing a significant number of virus antigen-
positive cells; and red indicates severe lung lesions in which the alveolar space was filled with inflammatory cells.
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involvement of monocyte and lymphocyte sub-populations
in the regulation of CA04 mediated pathology.
Particularly interesting was the observed up-regulation
of caspase 1 (CASP1) in CA04-infected lungs. CASP1 is
converted to its active form by the inflammasome signa-
ling complex, which is activated by influenza virus in-
fection [21,22]. In turn, CASP1 cleaves latent IL1β
and IL18 leading to the secretion of the activated
forms of these pro-inflammatory cytokines [23]. Consistent
with increased CASP1 expression, IL1β and IL18 protein
concentrations were elevated in the lungs of 2 of 3 CA04-
infected macaques at day 7 (see Additional files in [11]).
Taken together, these observations are indicative of
increased inflammasome activity in CA04 infections.
Among the CA04-down-regulated transcripts, we ob-
served several members of the cytosolic glutathione
S-transferase (GST) protein family (GSTT1 on day 3;
GSTT1, GSTM5, and GSTM4 on day 7). GSTs areantioxidant enzymes that participate in the inactivation
of secondary metabolites formed as a result of oxidative
stress, and thereby serve a protective role in the cell [24].
Similar suppression of GST transcription was observed in
the kidneys of chickens infected with an HPAI virus strain
[25], and it has been suggested that oxidative stress may
be a key pathway involved in lung injury associated with
HPAI virus infection [26]. Thus, the CA04-enhanced
down-regulation of GST likely promotes oxidative injury
in lung tissue.
CA04-infected macaques exhibit enhanced inflammatory
and cell cycle gene expression
IPA and DAVID were next used to identify functio-
nal differences between CA04 and KUTK4 infections
(Figure 2). IPA uses Fisher’s Exact test to determine the
enrichment significance for each function annotated in
the IPA database. DAVID, on the other hand, uses clus-
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Figure 2 The enriched biological functions of up-regulated genes, as determined by (left) IPA and (right) DAVID. The IPA enrichment
score is reported as the -log10 of the FDR-adjusted P-value. DAVID clusters redundant or highly related annotations into clusters and reports the
enrichment as the –log10 of the average P-value of the terms in each annotation cluster. DAVID did not identify any significant annotations for
genes which were up-regulated on day 3, and only enrichments for day 7 are shown.
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lates the enrichment score of a cluster by averaging
unadjusted P-values (determined by Fisher’s Exact test)
of the annotations within the cluster [15]. We reasoned
that analyzing the CA04 pathogenicity-associated DE
transcripts using both methods would provide increased
functional information and/or cross-validation between
methods. DE transcripts were separated into up-regulated
or down-regulated groups (CA04 expression relative to
KUTK4 expression) for each time point and analyzed se-
parately. All significantly enriched (FDR-adjusted P-value
< 0.01) IPA functional annotations and DAVID func-
tional clusters are included in Additional files 4 and 5,
respectively.
IPA analysis of up-regulated DE transcript identified
enrichment for ‘Inflammatory Response’, ‘Immune Cell
Trafficking’, and ‘Antigen Presentation’ at day 3 p.i., consis-
tent with the increased immune cell infiltrates observed in
the original pathology examination [11]; no significant
clusters were identified in this time point using DAVID
analysis (Figure 2). Transcripts up-regulated on day 7 were
enriched for many of the same IPA categories found on
day 3, and both IPA and DAVID identified ‘Cell Cycle’ as
being the most highly enriched, up-regulated process
on day 7. More specific categories, such as positive or
negative regulation of cell cycle, did not provide con-
clusive evidence as to the effect of the regulation on cell
cycle (see Additional files 5 and 6). Among the downregu-
lated transcripts, we saw enrichment only with IPA at the
7 d p.i. time point, and only in two categories with no
obvious connection to the host response to infection
(e.g., ‘Psychological Disorders’ and ‘Neurological Diseases’)
(Additional file 4). These results suggest that functional
differences between CA04 and KUTK4 initiate early
after infection and are amplified later in the infection,
while both analyses identified the cell cycle as the mostprominently enriched functional annotation for transcripts
that were highly DE with CA04 infection.
CA04 infection enhances gene expression associated with
both early/innate and late/adaptive immune cell
responses
As differences in immune cell subtypes can also be key
regulators of pathology, we performed a cell-specific, func-
tional analysis of DE genes by using IPA’s specialized func-
tional annotations for disease and discovery. In addition
to providing a general description of function for a cate-
gory of enriched genes, this approach captures details
such as the cell or tissue type in which the gene exerts its
function and the orientation of regulation. For down-
regulated genes on both days, few categories satisfied our
enrichment criteria (FDR-adjusted P < 0.05), and no
immune cell-specific annotations were enriched. In con-
trast, the up-regulated gene lists produced more than 500
enriched categories for both days, many of which exhibi-
ted functions pertaining to the activation, chemoattrac-
tion, infiltration and development of specific immune cell
subtypes (a complete list of significant categories for up-
and down-regulated genes is shown in Additional file 6).
To obtain a clearer representation of how CA04-induced
gene expression influences different immune cell sub-
types, we categorized enrichment by cell-type and func-
tion and employed a heat map to show how the enrich-
ment was distributed in relation to time (summarized in
Figure 3; see also Additional files 7 and 8 for a detailed
heat map). On day 3, the immune cell subtype most
prominently affected by CA04-enhanced gene expres-
sion was macrophages, for which categories related to
activation, accumulation, and chemotaxis were very highly
enriched (Figure 3). T lymphocytes and neutrophils
were also broadly affected at this time point, although
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Figure 3 Cell-specific CA04-induced functional enrichment. Cell-type specific enrichment of CA04-induced up-regulated DE transcripts is
shown for day 3 (left) and day 7 (right) post-infection. Enriched cell-type-specific IPA annotations (FDR-adjusted P-value < 0.05) were sorted
according to function (categories shown to the left of each panel) and cell-type (shown at the top of each panel), and the level of enrichment
was illustrated by a heat map showing the -log10-adjusted P-value for each annotation. Because P-values associated with highly related
annotations (e.g., ‘Cell Movement’, ‘Chemotaxis’ and ‘Trafficking’) were grouped together, a cell type could be enriched several times within a
particular category. Cell types with the highest enriched categories are shown in boldface (top), whereas cell types for which no categories were
enriched are shown in grey. All other cell types, exhibiting intermediate levels of enrichment in various categories, are represented in normal
black text. A color-key for the heat map is shown at the lower left of the figure, in which day 3 P-values are represented by the range above the
color bar and day 7 P-values are indicated below the bar.
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for genes affecting the migration of dendritic cells, eosi-
nophils, and natural killer cells. On day 7, no significant
terms related to natural killer cells or basophils were
observed, and enrichment of the activation and migration
of neutrophils was quite minor, demonstrating that several
aspects of the innate immune response had tapered.
Instead, we found high enrichment for B lymphocyte
proliferation and broad enrichment in categories asso-
ciated with T lymphocyte chemotaxis, infiltration, prolif-
eration, activation, and death. In addition, several
functions of antigen presenting cells (APCs) were more
up-regulated in the CA04 infection. The original pathol-
ogy results [11] did not specify the cell types that com-
prised the enhanced inflammatory infiltrates on day 3 in
CA04-infected lung tissue, but they did identify an
increase in APCs on day 7 p.i. [11]. These data point to an
increased presence and activation of primarily innateimmune cell subtypes early after infection, followed by
enhanced influx and activity of APCs and adaptive
immune cell types in CA04-infected macaque lungs.Inflammatory and apoptotic transcription factor binding
sites are enriched in CA04-specific DE genes
Next, transcription factor activity was determined by
identifying transcription factors whose promoter sequen-
ces were highly enriched among the genes that were DE
between the CA04 and KUTK4 infections. We used the
GATHER software tool [27] which matches transcrip-
tion factors with their experimentally proven binding
sites and determines whether there is significant enrich-
ment of a transcription factor binding site within a given
gene list. The transcription factors that matched the
most highly enriched promoter sequences for each time
point after infection are shown in Table 1.
Table 1 Top three transcription factors enriched for genes differentially expressed (DE) on day 3 or day 7 post-
infection between CA04 virus-infected and KUTK4 virus-infected lung tissue
Transcription factor % DE genes* -ln (P Value)
Day 3 Interferon Regulatory Factor 7 (IRF7) 55.8 3.54
Forkhead box P3 (FOXP3) 53.8 4.08
Hepatic nuclear factor 1 (HNF1A) 42.3 7.18
Day 7 MYC-associated zinc finger protein (MAZ) 74.6 6.05
Nuclear transcription factor Y alpha (NFYA) 24.4 8.31
Paired box 5 (PAX5) 15.7 5.56
* The percentage of genes DE on each day that were regulated by each transcription, according to GATHERW.
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feron regulatory factor 7 (IRF7), forkhead box P3 (FOXP3),
and hepatic nuclear factor 1 (HNF1A). IRF7 is activated by
toll-like receptors and RIG-I, and its increased activity
likely reflects the increased replication of CA04 in
macaque lungs observed on day 3 p.i. [11]. FOXP3 is
a transcription factor specific to a subset of regulatory
T lymphocytes that are known for suppressing inflam-
matory reactions [28]. FOXP3 promoter site enrichment
thus implicates regulatory T lymphocytes in the early
phase of CA04 infection, possibly reflecting an increased
requirement to confront the CA04-enhanced inflamma-
tory response. HNF1A has a wide range of functions, but
recent evidence suggests that it may serve as a link
between metabolic and inflammatory pathways involved
in atherosclerosis [29].
On day 7, nuclear transcription factor Y alpha (NFYA),
paired box 5 (PAX5) and MYC-associated zinc finger
protein (MAZ) transcription factor activities were highly
significant. NFYA directly induces transcription of many
pro-apoptotic genes and is implicated in p53-mediated
apoptosis [30,31]. To determine if there was any signifi-
cant association between the genes regulated by NFYA
and the genes annotated with ‘Cell Death’ in IPA, we
used a one-sided Fisher’s exact test, but we did not
observe significant overlap between these gene sets (only
13.9%, P = 0.18, of the DE genes that were annotated
for ‘Cell Death’ were also regulated by NFYA; further
limiting the gene set to only upregulated genes resulted
in a non-significant overlap of 22.0%, P = 0.69). PAX5 is
a specific marker for B cells [32], and its enrichment is
consistent with the enhanced B cell presence and activity
suggested by our cell type-specific functional enrichment
analysis for day 7 (Figure 3). The enriched transcription
factor affecting the greatest percentage of CA04 DE genes
was MAZ, whose regulation is strongly correlated to
inflammation and other common inflammatory markers
(e.g., IL6, IL1β) [33]. Significant overlap was identified
between the genes annotated for ‘Inflammation Response’ by
IPA and genes that contained the MAZ binding sequence,
when considering all DE genes on day 7 (72.3% overlap,
P = 0.05), but the overlap was not significant when onlyconsidering genes upregulated on day 7 (63.9% overlap,
P = 0.25). But within the set of upregulated genes, there was
a very significant overlap between the MAZ regulated gene
set and the set of genes annotated with “Cell cycle” in IPA
(74.5% overlap, P = 0.003). This suggests that MAZ is closely
associated to cell cycle activity despite its established role
in inflammation. Overall, transcription factor enrich-
ment analysis identified several factors involved in the reg-
ulation of inflammatory processes, apoptosis and cell
cycle, and is consistent with the enriched functional pro-
cesses observed among the genes that were more DE with
CA04 infection.
Network analysis identifies the primary gene expression
moderators in CA04-infected tissue
Thus far, we have used enrichment analyses to isolate indi-
vidual processes differently regulated by the CA04 virus.
Next, we applied a network approach to determine the
regulatory interactions that may be coordinating gene
expression. Within the IPA-curated human protein-
protein interaction (PPI) network, we searched for subnet-
works that were highly populated with DE genes, and
then we used the protein degree (i.e., the “centrality”, or
the number of interactions a protein has) to identify highly
connected hub proteins within each subnetwork. Hub
proteins are often more essential than non-hub proteins
[34,35] and may play critical roles in regulating the net-
work’s overall biological function [36].
An initial assessment allowing for a network size of up
to 70 members did not identify any significant subnet-
works at 3 d.p.i.; however, several were detected among
DE genes on day 7. The most significant of these was
highly enriched for ‘Cell Growth and Proliferation’ and
‘Inflammatory Response’ annotations (Fisher’s exact test
P-values < 10-15) and was centered on four hub genes:
IFNG, MYC, IL6, CDKN1A (Figure 4A, a more detailed
illustration in Additional file 9). A more restricted analysis
– limiting the number of subnetwork members to 35
genes – recapitulated this result, yielding three smaller
subnetworks with the same hub genes, each enriched for
unique biological functions (Figure 4B-D). IFNG, an anti-
viral cytokine with potent macrophage activation activity
A. Cell Growth and Proliferation/ 
Inflammatory Response  
B. Cellular Movement 
noitarefilorPdnahtworGlleC.DelcyClleC.C
Figure 4 Protein-protein interaction subnetworks differentially regulated in CA04-infected lung tissue. IPA was used to determine
subnetworks within the human PPI which were highly populated with genes differentially expressed in CA04-infected tissue on day 7 p.i. We
show the top networks (based on their network score) when (A) up to 70 proteins are allowed in the subnetwork and (B-D) the top 3 networks
when the size of the subnetwork is limited to 35 proteins. Each network is labeled according to its most enriched biological function. Proteins
that’s transcript is up-regulated or down-regulated in CA04-infected lung relative to KUTK4-infected lung are colored red and green, respectively.
Additional file 9 provides a larger illustration of panel A with all protein labels shown.
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exhibited high centrality in a largely upregulated subnet-
work that was enriched for ‘Cellular Movement’ (P-value
= 3.96E-16) (Figure 4B). Notably, 8 of the 35 proteins inthis subnetwork were also members of the ‘Role of Cyto-
kines in Mediating Communication between Immune
Cells’ canonical pathway (Additional file 10), thus
implicating IFNG as a putative regulator of the increased
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second subnetwork, consisting primarily of upregula-
ted genes, was highly enriched for ‘Cell Cycle’ functions
(P-values = 5.4E-7) (Figure 4C). Interestingly, both the
pro-inflammatory cytokine, IL6, and the cyclin-dependent
kinase inhibitor, CDKN1A, appeared as hubs within this
subnetwork, suggesting a novel connection between the
host inflammatory response and the highly enriched, cell
cycle-associated processes that occur in the late stage of
infection. CDKNIA’s involvement further suggests that the
broad category of “cell cycle” is likely to be more specifi-
cally related to cell cycle arrest, since CDKN1A is a known
inhibitor of cell cycle.
The final network (Figure 4D) is centered around the
MYC transcription factor, which was up-regulated in
CA04 infections, and enriched for ‘Cell Growth and Pro-
liferation’ (P-value = 2.0E-6). Generally, MYC activity is
associated with cell proliferation, but MYC overexpres-
sion has also been associated with cell cycle arrest [37].
As the majority of the genes in this subnetwork were
down-regulated in the CA04 infection, this suggests that
cell proliferation is being suppressed. Therefore, network
analysis results were consistent with previous enrich-
ment analyses, and further suggested that IFNG, IL6 and
CDKN1A may play prominent roles in regulating the
severity of CA04-associated disease relative to seasonal
influenza virus.
The CA04-KUTK4 differentially active immune network
Finally, we integrated the cell type enrichment and pro-
moter sequence enrichment analysis with the results
of the subnetwork analysis into a coherent map of the
CA04-induced immune response. To better clarify how
critically positioned hub proteins affected canonical path-
ways, we performed pathway enrichment and selected two
significantly enriched pathways – the ‘Role of Cytokines
in Mediating Communication between Immune Cells’
(Additional file 10) and the ‘Role of CHK Proteins in
Cell Cycle Checkpoint Control’ (Additional file 11) – for
further examination. These pathways were chosen because
(i) they contained several of the genes that mapped to the
subnetworks shown in Figure 4, (ii) the function of these
pathways matched the function of the subnetworks and
(iii) the pathway was highly enriched for genes DE in
CA04-infected lung (FDR-adjusted P < 0.05, Additional
file 12 provided details on the pathway enrichment analy-
sis). Furthermore, these pathways contain cell-specific
expression information for many of the genes involved in
this study.
Interactions within each pathway were diagrammed,
taking into consideration activating and inhibitory re-
lationships (Figure 5). Next, we searched the IPA PPI
database for interactions linking the pathways, and
we identified the MAZ transcription factor, which,incidentally, was also one of the most enriched transcription
factors in the promoter enrichment analysis. Specifically,
MAZ activates expression of CDKN1A (a component of
the CHK pathway and a ‘Cell Cycle’ subnetwork hub),
thereby controlling cell cycle progression through the G1
checkpoint [38] (see also Figure 5). MAZ is also activated
by both IL1 and IL6 through MAP kinase-dependent phos-
phorylation in human cells [39] and is a member of the
MYC complex. Thus, MAZ, in a network context, appears
to be a critical intermediary between the identified subnet-
works and potentially their biological function.
The newly identified interactions were added to the pre-
viously mentioned pathway diagrams, and gene expression
and differentially active transcription factors were overlaid
to depict the CA04-induced immune response (Figure 5).
The viral RNA sensing pathway was added since IRF7 was
found to be active in the CA04-infection on day 3 [40].
The precise cell-type in which cell cycle arrest and MAZ
activity occurs is an open question; therefore, the specific
type of infected cell was not clarified in the network, and
was labeled only as ‘Infected Cell’. CA04-enhanced DE
genes were colored red, and differentially active tran-
scription factors or the cell types their differential activity
may represent (e.g., FOX3P is regulatory T lymphocyte-
specific) were boxed in red (if enriched on day 3 p.i.) or
black (if enriched on day 7 p.i.). The full names and Entrez
IDs for all genes depicted in Figure 5 are listed in
Additional file 13.
In this network, only four genes (all chemokines) were
up-regulated on day 3 p.i. (demarcated by red stars) and
their primary role is the chemoattraction of innate
immune cell types (NK cells, neutrophils, macrophages,
and dendritic cells). The activity of IRF7 and regulatory
T lymphocytes (implicated by FOX3P enrichment) was
enhanced on day 3, as evidenced by the promoter
sequence enrichment (Table 1). Major differences in the
immune response network appeared on day 7 p.i., with
upregulation of additional chemokines and cytokines
responsible for the activation and differentiation of
innate and adaptive immune cells (see the non-starred
red nodes on the right panel of Figure 5). In particular,
interferon gamma (IFNG), which is important for cyto-
toxic T cell function and elimination of virus-infected
cells, was up-regulated (Figure 5, right). Additionally,
upregulation of IL6 and IL10 (Figure 1) can lead to B lym-
phocyte activation, while the presence of B lymphocytes
was supported by the enrichment of the PAX5 promoter
sequence (Table 1). Increased immune cell presence and
continued IL6 (and/or IL1) production would allow the
simultaneous upregulation of MAZ activity, thereby im-
pacting inflammatory and cell cycle signaling through
CDKN1A transcription (Figure 5, see the MAZ trans-
cription factor node and its incoming and outgoing












Figure 5 Differential response network between CA04- and KUTK4-infected lung tissue. Highly enriched canonical pathways identified by
using IPA (namely, ‘Role of CHK Proteins in Cell Cycle Checkpoint Control’, enclosed by the white, broken line and ‘Role of Cytokines in Mediating
Communication between Immune Cells’, enclosed by the blue broken line) were integrated by using highly enriched transcription factors and
IPA's Expert Curated protein-protein interaction database. Newly identified interactions which are not part of the canonical pathways are
illustrated with red arrows, whereas interactions belonging to the canonical pathways are colored black. Proteins that are differentially up-
regulated in CA04-infected lung tissue relative to KUTK4-infected lung tissue on day 7 p.i. are colored red. Three chemokines and one chemokine
receptor which were up-regulated in the CA04 infection on day 3 as well are demarcated by red stars adjacent the protein. Transcription factors
or cell types for which the transcription factors surrogate as cell markers are boxed in red or black representing enrichment on day 3 or day 7 p.i.,
respectively.
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in cell cycle arrest, since many of MYC’s target proteins
were downregulated during infection (Figure 4D). Overall,
our data identify a novel, transcriptionally active link bet-
ween influenza-induced inflammation and cell cycle
arrest (i.e., the MAZ transcription factor) and suggest that
inflammation-induced, MAZ-dependent cell cycle disrup-
tion may be responsible, at least in part, for apoptosis and
tissue injury related to influenza virus pathogenicity.
Discussion
GO and pathway enrichment studies can detail many key
aspects of the host response, but these biological functions
and processes must be integrated to create host response
models capable of linking the effects of transcription to
the molecular and signaling events driving those effects.
The differentially regulated host response network pre-
sented here represents a novel effort to combine various,
independent analyses of DE genes into a coherent protein-
protein/protein-cell type interaction architecture. This
approach allowed us to link immune cells and their
inflammatory activities with cell cycle regulation through
the identification of a transcription factor (i.e., MAZ) thatacts as an intermediary between these functional cor-
relates of pH1N1 pathogenicity. While many studies have
used microarrays to identify global transcriptional
changes that characterize the host response to differ-
ent influenza viruses in different systems, our integrated
approach allows for a more specific understanding of the
mechanisms of influenza virus-induced pathogenicity.
Prior to developing the differential host response net-
work, we validated our transcriptional data by showing
that it was, indeed, indicative of the pathological diffe-
rences between the two infections (Figures 2 and 3). Initial
functional enrichment results confirmed that the biolo-
gical processes observed during the pathology examina-
tion (i.e., enhanced inflammation and increased immune
cell infiltrates [11]) were also detectable in the transcrip-
tional differences between CA04- and KUTK4-infected
lung tissue. Therefore, it seems very likely that any addi-
tional functionality or pathway information derived from
these data should have a highly correlative, if not causal,
relationship with the enhanced pathology of the CA04
infection.
The enhanced ability of the CA04 virus to replicate in
lung tissue does not lead to large differences in the host
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transcription factor activity in CA04-infected lung is
consistent with the increased toll-like receptor/RIG-I
signaling one expects when there are increased levels of
viral single-stranded RNA present in a sample. Enhanced
chemoattraction of NK cells, dendritic cells, neutrophils,
and macrophages is consistent with the enhanced
inflammatory infiltrates observed on histopathologic exa-
mination. Most interesting is the implied difference in
regulatory T lymphocyte populations, evident from FOXP3
promoter site enrichment, and the potentially enhanced
IL-1β expression as a result of greater up-regulation of
CASP1 in the CA04 infection. Regulatory T lymphocytes
manage immune system homeostasis, and imbalances in
T cell populations are often associated with increased
inflammation and immune-mediated cell death [41,42].
The implicated regulatory T lymphocyte population change
may be a factor in the enhanced inflammation and cell da-
mage observed in CA04-infected lung tissue on day 3 p.i.
Additionally, increased CASP1 induction of IL-1β could
further promote inflammation in CA04-infected tissue.
In a previous study, lung samples infected with a highly
pathogenic and mildly pathogenic pH1N1 virus were
compared to KUTK4-infected tissue on day 1 p.i., and
similar to the work presented here, enhanced inflamma-
tion and immune cell infiltration were identified as corre-
lates of increased pH1N1 pathogenicity [7]. This study
found NFκB mediated transcription as a potential
mechanism of enhanced pathogenesis, but the degree to
which the observed gene regulation was independent of
viral replication is unclear. Furthermore, of the 101 tran-
scripts DE on day 3 of our study, only 11 were also DE in
the previous work. While this does represent a significant
overlap (Fisher Exact test; P < 0.001), none of the genes
identified as DE early in pH1N1-infected lung tissue in
both studies are related to the immune response. In all,
both studies show that early in the course of the infection,
there is no obvious dysregulation of the host response
with the potential exception of an imbalance in regulatory
T lymphocytes, noted above.
By day 7 p.i., several mechanisms up-regulated in
CA04-infected lung tissue can account for the continued
enhanced pathology [11]. Lung tissue infected with CA04
on day 7 p.i. showed sustained activation and accumula-
tion of immune cells despite the absence of replicating
virus. In addition to the increased immune cell signaling
and the activation of the adaptive immune response (evi-
dent by the B cell-specific PAX5 promoter site enrichment
and GO enrichment analysis shown in Figure 3) we
observed increased enrichment for cell cycle arrest. Cell
cycle arrest has a complicated relationship with virus
replication and the immune response. Arrest during G1
phase promotes greater influenza virus replication [43],
but cell cycle arrest also often occurs in cells prior toapoptosis [44]. Given that cell cycle arrest was observed
late in the infection, this is likely to be a host-controlled
event, possibly reflecting severely damaged host cells se-
lecting an apoptotic fate.
The MAZ transcription factor activity (Table 1) adds
an additional layer of complexity between influenza
infection-induced apoptosis, immune cell trafficking, and
the observed cell cycle arrest. MAZ increases cyclin-
dependent kinase inhibitor 1A (CDKN1A) expression [38]
and is known to regulate MYC transcription [45] – two
molecules with seemingly opposed effects on cell cycle.
Increased CDKN1A transcription leads to cell cycle arrest
and the production of serum amyloid A (SAA), which in
turn leads to increased recruitment of immune cells to
inflammatory sites [38,39,46]. Increased MYC transcrip-
tion is most often associated with increased proliferation
but it has also been linked to increased cell cycle arrest in
fibroblasts [37]. Since the cell proliferation enriched sub-
network holds MYC in a highly central position
(Figure 4D), the evidence suggests that the increased
MAZ transcription is simultaneously inducing cell
cycle arrest via CDKN1A and MYC pathways. Since
lymphocytes typically proliferate in organized lym-
phoid tissue (e.g., in lymph nodes) and our samples
were collected from within infected lung lesions, we
suggest that regulation of cell cycle gene expression pri-
marily occurs in infected epithelium or pneumocytes.
Lastly, the fact that virus could not be isolated on
day 7 for CA04 infected-lung tissue suggests that
activation of the MAZ pathway may be in response
to an overly aggressive immune response rather than
virus replication. Further, while MAZ protein levels
are directly correlated with chronic inflammation, the
anti-inflammatory suppression of CCL2 transcription
by CDKN1A [47] was not observed in our microarray
data. Thus, there are multiple interactions involving
MAZ which we feel are suitable targets to mitigate
inflammation during moderate to highly pathogenic influ-
enza infections. Further study validating the significance
of MAZ transcription to local inflammation is warranted.
The differentially regulated network developed here elu-
cidates differences between a low pathogenic and a mod-
erately pathogenic infection, and is likely a suitable model
of enhanced pathology in humans, as macaque models of
influenza virus infection are considered to be one of the
best surrogates of human infection [48]. Several chemo-
kines and interleukins that are up-regulated in the CA04
infection are also up-regulated in the lungs of macaques
infected with HPAI H5N1 virus [12]; however, promoter
enrichment analysis of avian virus-infected lung tissue
may be needed to provide greater clarity on the precise
mechanisms active during a highly pathogenic infection.
Ultimately, we intend to develop a mathematical model
that can quickly identify the correlates of pathogenicity
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regulation to infection severity in humans. The network
presented here is the first step toward developing such a
model.
Conclusions
In summary, CA04-infected macaque lungs showed a
prolonged immune response that continued beyond the
duration of the local virus infection. The failure of the
negative feedback mechanism that exists between MAZ,
CDKN1A, and macrophage cell migration (induced by
CCL2) could have caused this prolonged inflammation,
thereby promoting enhanced cell cycle arrest and apop-
tosis. The interplay between MAZ induction, immune
cell signaling, and inflammation must be finely tuned,
and failure to maintain an appropriate, balanced res-
ponse between these three factors could explain, at least
in part, the increased pathogenicity of CA04 and other
pH1N1 viruses. Further studies are needed to address
the interchange between MAZ, the cell cycle, and the
immune response, as well as the effects of this interplay
on influenza virus-induced disease pathology. Overall, our
strategy of linking functional annotations to the protein-
protein interaction networks is suitable for identifying the
key mechanisms driving the observed phenotypes.
Methods
Ethics statement
As previously reported in [11], all experiments were per-
formed in accordance to the Guidelines for the Husbandry
and Management of Laboratory Animals of the Research
Center for Animal Life Science at Shiga University of
Medical Science, Shiga, Japan and were approved by the
Shiga University of Medical Science’s Animal Experiment
Committee and Biosafety Committee.
Tissue samples
Lung tissues used for microarray studies were obtained
from thirteen female cynomolgus macaques infected with
influenza viruses as previously described [11]. Briefly,
six animals were inoculated with influenza A/California/
04/2009 (H1N1; referred to as CA04), a 2009 pH1N1 virus
isolate; six animals were inoculated with influenza
A/Kawasaki/UTK-4/2009 (H1N1; referred to as KUTK4),
a seasonal isolate; and one uninfected animal served as a
negative control. On days 3 and 7 post-infection (p.i.),
lung tissues were harvested from the middle and lo-
wer lung lobes of three animals in each infection group
(N = 26 total samples were collected), and all but three
samples were collected from visually apparent virus-
induced gross lesions. Two lung tissue samples were ob-
tained from middle and lower lobes of the uninfected
animal at the start of the experiment. A more detaileddescription of tissue sample location and lesion severity is
provided in Additional file 3.
RNA extraction
Macaque lung tissues were placed in the RNA stabiliza-
tion reagent RNAlater (Ambion, CA) and stored at -80°C.
All tissues were thawed together and homogenized
(2 minutes at 30 Hz) by using a TissueLyser (Qiagen,
Hilden, Germany), following the manufacturer’s instruc-
tions. Total RNA was extracted from homogenized
lung tissues with the RNeasy Mini Kit (Qiagen, Hilden,
Germany), according to the manufacturer’s recommendation.
Microarray, normalization, and statistical analysis
Extracted lung RNAs were sent to Takara Bio (Otsu,
Shiga, Japan) for microarray analysis. Briefly, sample integ-
rity and quantity were measured with the Agilent 2100
Bioanalyzer (Otsu, Shiga, Japan), which resulted in the
exclusion of three samples due to poor RNA quality. In
total, two mock-infected samples and at least five infected
samples from each infection group at each time point
were sent for subsequent microarray analysis. Cy3-labeled
cRNA preparations were hybridized with rhesus macaque
arrays (Agilent Microarray Design Identification Number
015421) for 17 h at 65°C. Feature Extraction Software ver-
sion 7 (Agilent Technologies) was used for image analysis
and data extraction, and Takara Bio provided whole array
quality control metrics.
Per chip probe intensity normalization and differential
expression (DE; DE also denotes “differentially expres-
sed”, e.g., DE genes) analysis was performed by using
GeneSpring GX version 11.0.2 (Agilent Technologies).
Individual probe quality control was performed by using
the GeneSpring default flag settings, requiring each
probe to satisfy the flag conditions for at least 4 of the
25 samples. DE genes were identified between virus
infection groups by use of one-way ANOVA comple-
mented with a Tukey Honestly Significant Difference
test, followed by a False Discovery Rate (FDR) correction
(Benjamini-Hochberg). Criteria for DE were as follows: an
absolute fold change > 2 and an FDR-adjusted P-value
< 0.01. All microarray data have been deposited Gene
Expression Omnibus (series number GSE39018) in accor-
dance with Minimum Information About a Microarray
Experiment (MIAME) guidelines.
Ingenuity pathway analysis
Functional and pathway enrichment analyses were per-
formed with Ingenuity Pathway Analysis (IPA) software
(Ingenuity Systems, Redwood, CA, USA), after match-
ing DE macaque genes with their human orthologs by
using GenBank Accession identification numbers. For
all functional and pathway enrichments, we required the
Benjamini-Hochberg corrected P-value to be < 0.05. For
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ficant function annotations were separated into their
function and respective cell types (e.g., ‘recruitment of
neutrophils’ was split into its function, ‘recruitment’,
and the cell-type, ‘neutrophil’). Further, functions that
were related were grouped together (e.g., ‘Cell Move-
ment’, ‘Chemotaxis’, and ‘Trafficking’); thus, one cell-type
may be significant more than once in each category. Addi-
tionally, leukocytes and mononuclear leukocytes were
grouped together. Many of the cellular processes (e.g., che-
motaxis, trafficking and cell movement) are highly related,
we grouped them accordingly. Instances in which the
same cell type is categorized into two cellular states (e.g.,
annotations related specifically to memory T cells or the
more broad characterization of simply a T cell) were gen-
eralized to T cells. Both of these factors can make a single
cell type appear enriched multiple times in each functional
category. For each day, genes that were up-regulated or
down-regulated when comparing CA04-infected lung tis-
sue to KUTK4-infected lung tissue were analyzed
separately.DAVID gene ontology analysis
The Genbank accession numbers of genes which were up
or down-regulated when comparing CA04-infected lung
tissue to KUTK4-infected tissue were analyzed in DAVID
[15,49] using DAVID default settings. In addition to the
enrichment scores for each annotation cluster produced
by DAVID, we also determined the cluster size; i.e., the
number of individual annotations which satisfied an FDR-
adjusted P-value <0.01.Transcription factor promoter sequence enrichment
analysis
The Genbank accession numbers of DE genes were ana-
lyzed in the GATHER [27] website to identify transcrip-
tion factors whose promoter sites were highly represented
within the data. GATHER employs the TRANSFAC 8.2
database, which contains data on transcription factors and
their experimentally validated binding sites. The human
genome R17 from the UCSC Genome Database was
matched to high quality matrices for vertebrate regulator
elements by applying the default score thresholds recom-
mended by TRANSFAC. Transcription factor binding
sites found 1200 bases upstream and 200 bases down-
stream of an annotated transcription start site were linked
to their RefSeq IDs, which were then mapped to their
Entrez Gene IDs based on the cross-references in the
Entrez Gene database. GATHER scores the enrichment by
using a P-value developed from the distribution of Bayes
factors developed from randomly sampling 10,000 genes.
Significant transcription factors were required to have
an adjusted P < 0.05. Full details of the algorithm andjustification for using the Bayes-based P-value is available
in the original GATHER publication [27].
Subnetwork construction
All subnetworks were constructed from the IPA PPI
network using IPA’s internal algorithm. Briefly, the IPA
algorithm identifies subnetworks by optimizing the in-
terconnectivity and number of user genes (genes DE on
each day) under the constraint of the selected network
size. For the studies described here, we limited subnet-
works to experimentally validated interactions identified
in humans, and we performed iterative analysis of net-
works restricted to 35 or 70 total members. The degree
of enrichment of DE genes in each subnetwork was
indicated by the -log10 of the right-tailed Fisher’s Exact
Test). Networks were constructed for each day separately.
Network integration
The results from the promoter sequence enrichment ana-
lysis and pathway enrichment analysis were integrated by
using protein-protein interaction data with the IPA in-
teraction database. Stringent conditions were applied to
identify binding interactions between the protein MAZ
and two highly enriched, canonical pathways, namely
“Role of CHK Proteins in Cell Cycle Checkpoint Control”
and “Role of Cytokines in Mediating Communication bet-
ween Immune Cells.” We required all added protein-
protein interactions between these two networks to be in
the Ingenuity Expert Findings and Ingenuity ExpertAssist
Findings, and further required that the interaction had
been verified in human lungs by using the setting within
the IPA software. For completeness, we also included the
viral RNA sensing pathway, as described in [40], to illus-
trate IRF7 activity on day 3 p.i.
Statistical analysis
All tests for significant overlap between two gene lists
were done in R using the one-sided Fisher’s exact test
for enrichment. When determining the overlap between
genes annotated with a select IPA term and genes con-
taining a selecting binding sequence (as determined by
GATHER), the gene symbols were first converted in-
to unique gene identifiers using the DAVID gene ID
converter.
Additional files
Additional file 1: Summary of the number of probes DE and the
number of DE probes which are chemokine ligands and receptors
(CCL/R), interleukins (IL) or interferon stimulated genes for each
day. Numbers in parenthesis show the number of up (left) and
down regulated genes (right). We also show the number of genes DE
on both days (intersection).
Additional file 2: All genes found differentially expressed on day 3
or 7 post infection.
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http://www.biomedcentral.com/1752-0509/6/117Additional file 3: Microarray data description file. File describes:
from which lobe the RNA was isolated; which virus the animal was
infected with; the day the sample was collected; the severity of the
lesions from which the sample was isolated, and the amount of
virus isolated from the region.
Additional file 4: Work Book Explanation: all genes lists were
separated into up- or down-regulated when comparing CA04-
infected tissue to KUTK4-infected. DE gene's Genbank Accession IDs
were uploaded into Ingenuity and the benjamini hochberg corrected
P-value was used to quantify enrichment.
Additional file 5: Work Book Explanation: all genes lists were
separated into up- or down-regulated when comparing CA04-
infected tissue to KUTK4-infected. DE gene's Genbank Accession IDs
were uploaded into DAVID and the benjamini hochberg corrected
P-value was used to quantify enrichment.
Additional file 6: Work Book Explanation: cell specific gene
ontology enrichment. All genes lists were separated into up- or
down-regulated when comparing CA04-infected tissue to KUTK4-
infected. DE gene's Genbank Accession ID was uploaded into Ingenuity
and the benjamini hochberg corrected P-value was used to quantify
enrichment. Here we report all categories with a FDR adjusted
P-value < 0.05.
Additional file 7: Cell-specific CA04-induced functional enrichment
on day 3 PI. This is an enlarged illustration of Figure 3A which provides
information on the specific function of each enriched IPA annotation.
Additional file 8: Cell-specific CA04-induced functional enrichment
on day 7 PI. This is an enlarged illustration of Figure 3B which provides
information on the specific function of each enriched IPA annotation.
Additional file 9: The subnetwork of the human PPI which contains
70 proteins whose transcripts were significantly expressed in CA04-
infected tissue. This network was identified using IPA. Up-regulated
genes are colored red while down-regulated genes are colored green.
Additional file 10: The "Role of Cytokines in Mediating
Communication between Immune Cells" Pathway from the IPA
database. Proteins colored red were identified as upregulated in
CA04-infected tissue. Interactions which promote protein production or
cell proliferation are illustrates with arrows. Inhibitory interactions are
illustrated with ┴.
Additional file 11: The "Role of CHK Proteins in Cell Cycle" Pathway
from the IPA database. Proteins colored red were identified as
upregulated in CA04-infected tissue. Interactions which promote protein
production or cell proliferation are illustrates with arrows. Inhibitory
interactions are illustrated with ┴. Interactions which promote a
particular phenotype (e.g., G2/S arrest) are illustrated with lines ending in
a circle.
Additional file 12: Work Book Explanation: enriched canonical
biological pathways for genes differentially expressed between
CA04 and KUTK4 infections.
Additional file 13: Work Book Explanation: official names, symbols
and accession numbers of all proteins shown in Figure 5.
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